
浏览全部资源
扫码关注微信
1.中国中医科学院 西苑医院 基础医学研究所 中药药理北京市重点实验室,北京 100091
2.新疆医科大学 附属中医医院,乌鲁木齐 830000
郭浩,博士,助理研究员,从事中药心血管药理研究工作,Tel:010-62835604,E-mail:g0502g@163.com
刘建勋,博士,研究员,从事中医药研发工作,Tel:010-62835601,E-mail:liujx0324@sina.com
收稿日期:2019-10-22,
网络出版日期:2020-08-14,
纸质出版日期:2020-10-20
移动端阅览
郭浩,任建勋,李磊等.芪红胶囊对心衰模型比格犬血流动力学及血氧含量的影响[J].中国实验方剂学杂志,2020,26(20):67-73.
GUO Hao,REN Jian-xun,LI Lei,et al.Effect of Qihong Capsule on Heart Hemodynamics and Myocardial Consumption of Oxygen in Heart Failure Model Beagle[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(20):67-73.
郭浩,任建勋,李磊等.芪红胶囊对心衰模型比格犬血流动力学及血氧含量的影响[J].中国实验方剂学杂志,2020,26(20):67-73. DOI: 10.13422/j.cnki.syfjx.20202043.
GUO Hao,REN Jian-xun,LI Lei,et al.Effect of Qihong Capsule on Heart Hemodynamics and Myocardial Consumption of Oxygen in Heart Failure Model Beagle[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(20):67-73. DOI: 10.13422/j.cnki.syfjx.20202043.
目的
2
从血流动力学及血氧含量等相关指标的角度探讨芪红胶囊对戊巴比妥钠诱导心衰模型比格犬的治疗作用。
方法
2
采用健康成年比格犬30只,随机分为6组,每组6只,分别为正常组,模型组,地高辛片组(40 μg·kg
-1
),芪红胶囊高、中、低剂量组(2.6,1.3,0.65 g·kg
-1
),采用静脉泵注2%戊巴比妥钠的方法建立比格犬心衰模型,以左室内压上升最大速率降低70%作为模型成功的标准,后经十二指肠给予相应药物,用多道生理记录仪分别测量肢体标准Ⅱ导联心电图、冠状动脉血流量、心输出量、左室内压、左室内压上升最大速率。罗氏血氧分析仪测定不同时间点动脉血氧含量、冠状静脉窦血氧含量,并计算心肌氧利用率。
结果
2
比格犬在静脉泵注2%戊巴比妥钠15 min左右,开始出现明显心衰症状,主要表现Ⅱ导心电图PR间期增加,冠脉血流量、左室内压、心输出量、心搏出量、静脉血氧含量显著降低、而心肌氧利用率显著增高,与正常组比较有显著差异(
P
<
0.01),为与模型组比较,1.3 g·kg
-1
芪红胶囊在给药后60~120 min显著增加冠脉血流量(
P
<
0.05),其最大增幅为36%,2.6 g·kg
-1
芪红胶囊在给药后45~60 min心搏出量增加明显,最大增幅约16%,与模型组比较有显著差异(
P
<
0.05)。同时能够增加冠静脉窦血氧含量,提示心肌供氧量升高,氧用率降低,芪红胶囊1.3 g·kg
-1
组给药60 min后能显著增加左室内压上升最大速率(
P
<
0.05),最大增幅约42%。
结论
2
芪红胶囊能够同时增加冠脉血流量及静脉血氧含量,使得心肌养供应充分,氧的利用率降低,在此基础上,芪红胶囊才能进一步增加心输出量和改善心脏功能,从而发挥心衰保护的作用。
Objective
2
To investigate the therapeutic effect of Qihong capsule on pentobarbital sodium induced heart failure in beagle dogs.
Method
2
Thirty healthy adult beagle dogs were randomly divided into 6 groups
6 in each group. They were normal group
model group
digoxin tablet group (40 μg·kg
-1
)
Qihong capsule high
medium and low dose groups (2.6,1.3,0.65 g·kg
-1
). The heart failure model of beagle dogs was established by intravenous infusion of 2% pentobarbital sodium. The success standard of the model was that the maximum rate of rise of left ventricular pressure was reduced by 70%.The corresponding drugs were given through duodenum. The Ⅱ lead electrocardiogram
coronary blood flow
cardiac output
left ventricular pressure and maximum rate of left ventricular pressure rise were measured by multi-channel physiological recorder. The arterial oxygen content and coronary sinus oxygen content were measured by Roche blood oxygen analyzer at different time points
and the myocardial oxygen utilization rate was calculated.
Result
2
After intravenous infusion of 2% pentobarbital sodium for about 15 minutes
beagle dogs began to show obvious symptoms of heart failure. The main manifestations were the increase of PR interval of Ⅱ lead electrocardiogram
the decrease of coronary blood flow
left ventricular pressure
cardiac output
cardiac output
venous oxygen content
and the increase of myocardial oxygen utilization rate (
P
<
0.01) compared with the model group
Qihong capsule significantly increased coronary blood flow at 60-120 min after treatment (
P
<
0.05). The cardiac output of 2.6 g·kg
-1
Qihong capsule increased significantly at 45-60 min after treatment
with the maximum increase of about 16%
which was significantly different from that of model group (
P
<
0.05). At the same time
it can increase the oxygen content of coronary sinus blood
which indicates that the myocardial oxygen supply is increased and the oxygen utilization rate is decreased. Qihong capsule 1.3 g·kg
-1
group significantly increased the maximum rate of left ventricular pressure rise (
P
<
0.05)
the maximum increase rate was about 42%.
Conclusion
2
Qihong capsule can increase coronary blood flow and venous blood oxygen content at the same time
make myocardial nutrient supply sufficient
reduce oxygen utilization rate
on this basis
Qihong capsule can further increase cardiac output and improve cardiac function
so as to play a protective role in heart failure.
ABI-SAMRA F , GUTTERMAN D . Cardiac contractility modulation:a novel approach for the treatment of heart failure [J]. Heart Fail Rev , 2016 , 21 ( 6 ): 645 - 660 .
王荣辉 , 曾广权 , 谢统辉 , 等 . 美托洛尔治疗慢性心力衰竭的5年远期随访资料分析 [J]. 中国实用医药 , 2018 , 13 ( 15 ): 8 - 10 .
王臻 , 李洁白 , 董昕 , 等 . 补阳还五汤对舒张性心衰大鼠心肌线粒体能量代谢及AMPK/PPAR α 信号通路的影响 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 9 ): 12 - 17 .
张国顺 , 白义萍 , 王小兰 , 等 . 葶苈子抗心衰有效组分筛选及其作用机制分析 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 4 ): 118 - 125 .
王倩 , 姚耿圳 , 潘光明 , 等 . 基于数据挖掘的慢性心力衰竭气虚血瘀证用药规律分析 [J]. 中国中药杂志 , 2017 , 42 ( 1 ): 182 - 186 .
刘兆龙 , 聂继红 , 张艳君 . 芪红胶囊水提工艺研究 [J]. 中国民族民间医药 , 2011 , 20 ( 20 ): 28 - 29,32 .
刘兆龙 , 聂继红 , 夏昌隆 . 芪红胶囊醇提工艺的研究 [J]. 新疆医科大学学报 , 2009 , 32 ( 12 ): 1696 - 1697 .
宋晓东 , 嵇波 , 刘玉清 . 芪红胶囊对柯萨奇病毒引起细胞凋亡的影响 [J]. 中国中西医结合杂志 , 2005 , 25 ( 6 ): 511 - 515 .
王仑 , 宋晓东 , 嵇波 , 等 . 芪红胶囊对病毒性心肌炎小鼠的保护作用 [J]. 北京中医药大学学报 , 2005 , 28 ( 2 ): 56 - 59 .
宋晓东 , 辛颖 , 刘哲 , 等 . 芪红胶囊通过免疫调节治疗病毒性心肌炎小鼠 [J]. 中国实验动物学报 , 2009 , 17 ( 2 ): 85 - 89 .
阿热依·贾尔肯 . 芪红胶囊治疗慢性心力衰竭气虚血瘀证的临床疗效观察 [D]. 乌鲁木齐 : 新疆医科大学 , 2018 .
仝淼 , 范辉 , 高玉 , 等 . 心脉隆注射液联合芪红胶囊治疗难治性心力衰竭的临床研究 [J]. 中西医结合心脑血管病杂志 , 2016 , 14 ( 16 ): 1825 - 1828 .
曹雪琴 . 芪红胶囊佐治酒精性心肌病的临床疗效评价 [J]. 中西医结合心血管病电子杂志 , 2016 , 4 ( 32 ): 49 .
徐淑云 , 卞如濂 , 陈修 . 药理实验方法学 [M].3版.北京 :人民卫生出版社 , 2002 : 1861 - 1863 .
卢志强 , 张艳军 , 庄朋伟 , 等 . 附子对急性心力衰竭大鼠血流动力学影响及其机制研究 [J]. 中草药 , 2015 , 46 ( 21 ): 3223 - 3227 .
冉亚军 , 陈继红 , 王晓峰 . 芪红散治疗心衰经验 [J]. 中国实验方剂学杂志 , 2012 , 18 ( 24 ): 340 - 342 .
李磊 , 刘建勋 , 任建勋 , 等 . 祛瘀化痰通脉颗粒对比格犬心脏血流动力学及心肌耗氧量的影响 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 9 ): 90 - 98 .
0
浏览量
17
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621